Aspirin prevention in early pregnancy after frozen embryo transfer
Treatments studied
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This trial tests whether taking baby-dose aspirin after a frozen embryo transfer can lower the chance of developing pre-eclampsia, a blood-pressure problem that can happen during pregnancy. It targets women considered at higher risk based on specific health factors and pregnancy details.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 43 years old and plan a frozen embryo transfer (natural or hormone/medication cycle is okay)
- You agree to take part in the study and have confirmed pregnancy at about 6 weeks of pregnancy (6 weeks without a period)
- You do not have any single listed pre-eclampsia risk factor (like prior pre-eclampsia or certain medical conditions)
- You can take acetylsalicylic acid (aspirin) safely—no current bleeding risk, stomach/ulcer risk, or serious liver/kidney problems in this context
- You are not already taking aspirin, and you are not taking blood thinners or certain pain/anti-inflammatory medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking low-dose aspirin after giving birth can help people who had preeclampsia. It aims to see if aspirin can lower the risk of future heart problems.
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
This study tests whether taking a low dose of aspirin early in pregnancy can lower the risk of losing the baby or developing preeclampsia (a serious condition with high blood pressure). It is for women who have risk factors for these problems and are very early in pregnancy (less than 7 weeks).
This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.
This Phase 3 study tests whether daily low-dose aspirin can reduce the risk of preeclampsia (dangerous high blood pressure in pregnancy) and improve pregnancy outcomes for people who got pregnant using assisted reproduction like IVF. It mainly targets pregnancies early on (about 9–14 weeks).
This study looks at whether taking aspirin for a longer or shorter time during pregnancy can better prevent preeclampsia, a serious condition with high blood pressure. It is for pregnant women already taking daily aspirin and found to be at high risk.
Hear when a new Embryo Transfer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.